Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY85-8501 in Non-CF Bronchiectasis
NCT01818544Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of PHP-303 in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Bayer. Started Apr 2013; status: completed.
02
Drugs
PHP-303
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT01818544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01818544.